EXOMIND (BTL-995) for Reduction of Binge-eating

计划入组 23 人 · 首次发布于 2025 年 4 月 4 日

EXOMIND (BTL-995) for the Reduction of Binge-eating

计划入组 16 人 · 首次发布于 2025 年 3 月 25 日

EXOMIND (BTL-699) for the Reduction of Food Cravings

计划入组 29 人 · 首次发布于 2025 年 3 月 21 日

Mescaline(Biomind Labs)

GenOmind, LLC

United States

Elemind Technologies, Inc.

United States

Biomind Labs Inc.

Canada

BTL Industries Receives FDA Clearance to Expand EMFACE Platform for TMJ Dysfunction Treatment

Biomind Labs Highlights Growing U.S. Support for Psychedelic Therapies

Enhanced TSOS Intervention Shows Promise for Trauma Survivors in Australia